help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinha, Y. N.
Right arrow Articles by Jacobsen, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinha, Y. N.
Right arrow Articles by Jacobsen, B. P.

Journal of Clinical Endocrinology & Metabolism, Vol 78, 1411-1418, Copyright © 1994 by Endocrine Society

ARTICLES

Human growth hormone (hGH)-(44-191), a reportedly diabetogenic fragment of hGH, circulates in human blood: measurement by radioimmunoassay

YN Sinha and BP Jacobsen
Department of Biochemistry and Clinical Physiology, Whittier Institute for Diabetes and Endocrinology, La Jolla, California 92037.

The purpose of these experiments was to determine whether a 17- kilodalton (K) fragment of human GH (hGH), hGH-(44-191), a peptide 10 times more potent than intact hGH in causing glucose intolerance in an animal model, circulates in human blood. Analysis of pituitary extracts and sera by Western blotting revealed the presence of a 17K hGH- immunoreactive band in both samples. Monoclonal antibodies to recombinant hGH-(44-191) cross-reacted with the 17K hGH-immunoreactive band of the pituitary. A RIA specific for hGH-(44-191) was developed using recombinant hGH-(44-191) as the tracer and standard, and a mouse anti-hGH-(44-191) serum as the source of antibody. The RIA detected hGH- (44-191) in human sera and pituitary extracts. The concentration of hGH- (44-191) in pituitary glands was 1/100th to 1/500th of the hGH concentration, but in serum its concentration averaged 1-2 times higher than that of hGH. Serum hGH-(44-191) concentrations were higher in pregnant than in nonpregnant women. The data document the existence of hGH-(44-191) in human pituitary gland and serum, and provide initial evidence that it may be physiologically produced. As its concentration is affected by the physiological state of the individual, it may play a role in the expression of the physiological and pathological actions of hGH.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. D. Wallace, R. C. Cuneo, M. Bidlingmaier, P. A. Lundberg, L. Carlsson, C. L. Boguszewski, J. Hay, M.-L. Healy, R. Napoli, R. Dall, et al.
The Response of Molecular Isoforms of Growth Hormone to Acute Exercise in Trained Adult Males
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 200 - 206.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Heffernan, W. J. Jiang, A. W. Thorburn, and F. M. Ng
Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism
Am J Physiol Endocrinol Metab, September 1, 2000; 279(3): E501 - E507.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Jansson, C. Boguszewski, S. Rosberg, L. Carlsson, and K. Albertsson-Wikland
Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein
Clin. Chem., June 1, 1997; 43(6): 950 - 956.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society